Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| ID | DOID:0070779 |
| Name | hormone receptor-positive/HER2-positive breast cancer |
| Definition | A HER2 positive breast cancer characterized by excess HER2 (ERBB2) protein and at least one of the estrogen or progesterone receptors. |
| Source | DiseaseOntology.org |
| Alt Ids | |
| Xrefs |
|
| Path | disease disease of cellular proliferation cancer organ system cancer breast cancer HER2 positive breast cancer hormone receptor-positive/HER2-positive breast cancer |
| Molecular Profile | Therapy | Indication/Tumor Type | Response Type | Profile Response Detail |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT04557449 | Phase Ib/II | Letrozole + PF-07220060 Fulvestrant + PF-07220060 PF-07220060 + Tamoxifen Giredestrant + PF-07220060 Enzalutamide + PF-07220060 PF-07220060 Midazolam + PF-07220060 | Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors (CDK4i) | Recruiting | USA | SVK | GBR | CZE | ARG | 3 |